Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
South Korea · Delayed Price · Currency is KRW 12,210
+10 (0.08%)
At close: Jul 31, 2026
Sam-A Pharm. Market Cap
Sam-A Pharm. has a market cap or net worth of 74.52 billion as of July 31, 2026. Its market cap has decreased by -33.28% in one year.
Market Cap
74.52B
Enterprise Value
-22.26B
Revenue
70.93B
Ranking
n/a
PE Ratio
8.39
Stock Price
12,210.00
ChartMarket Cap Chart
Since November 29, 2000, Sam-A Pharm.'s market cap has increased from 32.75B to 74.52B, an increase of 127.56%. That is a compound annual growth rate of 3.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 74.52B | -22.28% |
| Dec 30, 2025 | 95.88B | -5.98% |
| Dec 30, 2024 | 101.99B | 1.89% |
| Dec 28, 2023 | 100.09B | -1.50% |
| Dec 29, 2022 | 101.62B | -13.95% |
| Dec 30, 2021 | 118.10B | 16.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OPTUS Pharmaceutical | 88.14B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 85.27B |
| H.PIO | 84.72B |
| KOREA PHARMA | 76.67B |
| Daehan Nupharm | 75.65B |
| Hwail Pharmaceutical | 73.65B |
| HL GENOMICS | 70.82B |
| Optipharm.CO.,LTD | 65.72B |